Biology subjects

Chai, S.

Publications and source records attributed to Chai, S..

4 recordsLinked to original sources

bioRxiv2023

Cell networks in the mouse liver during partial hepatectomy

In solid tissues homeostasis and regeneration after injury involve a complex interplay between many different cell types. The mammalian liver harbors numerous epithelial and non-epithelial cells and little is known about the global signaling networks that govern their interactions. To better understand the hepatic cell network, we isolated and purified 10 different cell populations from normal and regenerative mouse livers. Their transcriptomes were analyzed by bulk RNA-seq and a computational platform was used to analyze the cell-cell and ligand-receptor interactions among the 10 populations. Over 50,000 potential cell-cell interactions were found in both the ground state and after partial hepatectomy. Importantly, about half of these differed between the two states, indicating massive changes in the cell network during regeneration. Our study provides the first comprehensive database of potential cell-cell interactions in mammalian liver cell homeostasis and regeneration. With the help of this prediction model, we identified and validated two previously unknown signaling interactions involved in accelerating and delaying liver regeneration. Overall, we provide a novel platform for investigating autocrine/paracrine pathways in tissue regeneration, which can be adapted to other complex multicellular systems. HighlightsA platform predicting cell-cell interactions in liver regeneration was established This platform identified the BMP4 pathway antagonist Fstl1 as a stimulator of hepatocyte proliferation This platform also discovered the role of Wnt pathway inhibitor Sfrp1 delaying liver regeneration

cell biology↗

bioRxiv2023

Effect of Intermittent Pneumatic Compression on Preventing Deep Vein Thrombosis Using Microfluidic Vein Chip

Deep vein thrombosis (DVT) is a common disease often occurring in the lower limb veins of bedridden patients. Intermittent pneumatic compression (IPC) has been considered an effective approach to solve this problem. In our previous research, 264 patients were randomly treated either with IPC for one or eight hours per day. The incidence of severe venous thrombosis was significantly lowered in the IPC group than in the control group. However, it is still a chanllenge to real-time monitoring the blood flow and thrombus formation process during IPC operation periods. Here we made a microfluidic vein chip with valves embedded in a flexible channel that can mimic the compression of vessels by IPC contractrion. Driven by inlet blood velocity obtained clinally, numerical simulation were conducted to identify the shear stress and laminar pressure distribution in the vein. The obtained results showed that the thrombus formation can be reduced with Higher compressive pressure and smaller time interval. 24s interval time and 40mmHg maximum contractive pressure was considered to be the most appropriate parameters for DVT prevention. This vein chip offers a new approach in vitro to observe the working mechanism of IPC device, offering important data for its further clinical standard regulation.

bioengineering↗

bioRxiv2022

LENS - Landscape of Effective Neoantigens Software

MotivationElimination of cancer cells by T cells is a critical mechanism of anti-tumor immunity and cancer immunotherapy response. T cells recognize cancer cells by engagement of T cell receptors with peptide epitopes presented by major histocompatibility complex (MHC) molecules on the cancer cell surface. Peptide epitopes can be derived from antigen proteins coded for by multiple genomic sources. Bioinformatics tools used to identify tumor-specific epitopes via analysis of DNA and RNA sequencing data have largely focused on epitopes derived from somatic variants, though a smaller number have evaluated potential antigens from other genomic sources. ResultsWe report here an open-source workflow utilizing the Nextflow DSL2 workflow manager, Landscape of Effective Neoantigen Software (LENS), which predicts tumor-specific and tumor-associated antigens from single nucleotide variants, insertions and deletions, fusion events, splice variants, cancer testis antigens, overexpressed self-antigens, viruses, and endogenous retroviruses. The primary advantage of LENS is that it expands the breadth of genomic sources of discoverable tumor antigens using genomics data. Other advantages include modularity, extensibility, ease of use, and harmonization of relative expression level and immunogenicity prediction across multiple genomic sources. We present an analysis of 115 acute myeloid leukemia (AML) samples to demonstrate the utility of LENS. We expect LENS will be a valuable platform and resource for T cell epitope discovery bioinformatics, especially in cancers with few somatic variants where tumor-specific epitopes from alternative genomic sources are an elevated priority. AvailabilityMore information about LENS, including workflow documentation and instructions, can be found at https://gitlab.com/landscape-of-effective-neoantigens-software Contactsteven_vensko@med.unc.edu, benjamin_vincent@med.unc.edu Supplementary informationSupplementary data are available at Bioinformatics online.

cancer biology↗

bioRxiv2020

Genome assembly and transcriptome analysis provide insights into the anti-schistosome mechanism of Microtus fortis

Microtus fortis (M. fortis) so far is the only mammal host that exhibits intrinsic resistance against Schistosoma japonicum infection. However, the underlying molecular mechanisms of this intrinsic resistance are not yet known. Here we performed the first de novo genome assembly of M. fortis, comprehensive gene annotation and evolution analysis. Furthermore, we compared the recovery rate of schistosome, pathological change and liver transcriptome between non-permissive host M. fortis and susceptible host mouse at different time points after Schistosome infection. We reveal that Immune response of M. fortis and mouse is different in time and type. M. fortis activates immune and inflammatory responses on the 10th days post infection, involving in multiple pathways, such as leukocyte extravasation, antibody activation (especially IgG3), Fc-gamma receptor mediated phagocytosis, and interferon signaling cascade. The strong immune responses of M. fortis in early stages of infection play important roles in preventing the development of schistosome. On the contrary, intense immune response occurred in mouse in late stages of infection (28~42 days post infection), and cannot eliminate schistosome. Infected mouse suffers severe pathological injury and continuous decrease of important functions such as cell cycle and lipid metabolism. Our findings offer new insights to the intrinsic resistance mechanism of M. fortis against schistosome infection. The genome sequence also provides bases for future studies of other important traits in M. fortis.

bioinformatics↗